Higher osimertinib introduction rate achieved by multiple repeated rebiopsy after acquired resistance to first/second generation EGFR‐TKIs von Ninomaru, Taira, Hata, Akito, Kokan, Chiyuki, Okada, Hideaki, Tomimatsu, Hirotaka, Ishida, Jun

Volltext

Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical... von Irie, Kei, Shobu, Saori, Hiratsuji, Seika, Yamasaki, Yuta, Nanjo, Shigeki, Kokan, Chiyuki, Hata, Akito, Kaji, Reiko, Masago, Katsuhiro, Fujita, Shiro, Okada, Yutaka, Katakami, Nobuyuki, Fukushima, Shoji

Volltext

Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations von Uchibori, Ken, Satouchi, Miyako, Sueoka-Aragane, Naoko, Urata, Yoshiko, Sato, Akemi, Imamura, Fumio, Inoue, Takako, Tachihara, Motoko, Kobayashi, Kazuyuki, Katakami, Nobuyuki, Kokan, Chiyuki, Hirashima, Tomonori, Iwanaga, Kentaro, Mori, Masahide, Aoe, Keisuke, Morita, Satoshi, Negoro, Shunichi

Volltext

IS2-3. Clinical predictive factors of atezolizumab monotherapy in pretreated non-small cell lung cancer von Taira Ninomaru, Akito Hata, Chiyuki Kokan, Yoshimi Fujishima, Hideaki Okada

Volltext

Development and validation of a method for epidermal growth factor receptor tyrosine kinase inhibitors quantification in dried blood spots: practices of pharmacist assisted self-bl... von Irie, Kei, Nanjo, Shigeki, Masago, Katsuhiro, Hata, Akito, Kokan, Chiyuki, Kaji, Reiko, Fujita, Shiro, Okada, Yutaka, Katakami, Nobuyuki, Fukushima, Shoji

Volltext